首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Corneoscleral transplantation for end stage corneal disease
【2h】

Corneoscleral transplantation for end stage corneal disease

机译:角膜巩膜移植治疗晚期角膜疾病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM—To describe the prognosis and complications of corneoscleral transplantation in the management of end stage eye disease.
METHODS—A case series is presented of 23 patients who have undergone corneoscleral transplantation (⩾11 mm). Patients were examined for visual acuity, intraocular pressure, recurrence of disease process, epithelialisation of the graft, signs of rejection, and other potential complications.
RESULTS—14 patients retained their eye, with six maintaining a clear graft. Vision ranged from 6/30 to no perception of light. 13 patients developed glaucoma (range 25-69 mm Hg), with six patients requiring surgical intervention. 12 patients required tarsorrhaphy to promote epithelialisation. Only two grafts resulted in typical rejection.
CONCLUSIONS—The technique of corneoscleral transplantation can salvage otherwise end stage eye disease, but the results are poor with respect to maintenance of vision. These patients need careful follow up because of potential complications of glaucoma, epithelial defects, rejection, and recurrence of disease.

Keywords: corneoscleral graft; end stage corneal disease; sclerokeratoplasty
机译:目的:描述角膜巩膜移植在终末期眼病治疗中的预后和并发症。
方法:介绍了23例接受角膜巩膜移植(⩾11mm)的患者的病例系列。检查了患者的视敏度,眼压,疾病过程的复发,移植物的上皮化,排斥反应的迹象以及其他潜在的并发症。
结果-14例患者保留了眼睛,其中6例保持了透明的移植。视觉范围从6/30到无光。 13名 患者出现青光眼(范围为25-69 mm Hg),其中六名患者需要手术干预。 12位患者需要镜检以促进上皮形成。结论:只有两个移植物会导致典型的排斥反应。
结论—角膜巩膜移植技术可以挽救其他晚期眼疾,但在维持视力方面效果不佳。由于青光眼的潜在并发症,上皮缺损,排斥反应和疾病复发,这些患者需要仔细随访。

终末期角膜疾病;巩膜角膜成形术

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号